975 articles in this topic
TONTT2 tests whether erythropoietin dose and timing can be optimized to best preserve vision after traumatic optic neuropathy.
A 210-person trial tests whether 5-month music therapy programs — and robotic assistants — can slow cognitive decline in older adults.
A published erratum flags missing funding and funder role information in a recent JAMA Neurology study, raising transparency questions.
A cohort of 18,000+ children and adults self-reported seizure durations, revealing patterns that could reshape clinical tracking and care.
New research reveals that cognitively resilient brains use fewer, more stable neurons — a finding that could unlock therapies to delay dementia.
An expert panel maps the pathways linking urban greenspace to Alzheimer's risk and offers researchers a standardized measurement playbook.
World-renowned lipidologist Tom Dayspring explains why brain cholesterol operates independently from the body — and what that means for Alzheimer's.
A 6,000+ organoid study links specific cellular phenotypes to microcephaly, polymicrogyria, epilepsy, and intellectual disability with 92% classification accuracy.
New research reveals that the molecular state of immature neurons in the aged hippocampus predicts cognitive resilience — not just their number.
A Phase II trial tests whether blocking herpes virus activity can protect against Alzheimer's disease in early cognitive decline.
A specific cholinergic brain circuit drives post-surgery memory decline in aging — and reactivating it rescues both cognition and neurogenesis.
Columbia researchers reveal how basolateral amygdala neurons juggle multiple emotional variables simultaneously, enabling precise behavioral readouts.
